Project documents | Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 146 KB)

Published:

14 April 2025
Final stakeholder list (PDF 148 KB)

Published:

14 April 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 137 KB)

Published:

14 April 2025
Equality impact assessment (scoping) (PDF 103 KB)

Published:

14 April 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 152 KB)

Published:

24 February 2025
Draft matrix of consultees and commentators post referral (PDF 148 KB)

Published:

24 February 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 216 KB)

Published:

16 January 2024
Draft matrix post referral (PDF 220 KB)

Published:

16 January 2024